(login)

Leading pharmaceutical
company in the Baltic States

Stock news


2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
On changes in the Management of «Grindeks»
27.04.2012
The joint stock company «Grindeks» informs that it has received the statement of Lipmans Zeligmans on his resignation from the positions of the Board Member and Director of the Final Dosage Forms Manufacturing of «Grindeks» on his own volition with effect from 01 May this year.

Read more


On «Grindeks» audited financial results for 2011
27.04.2012
Today, on 26 April, JSC «Grindeks» has submitted the audited consolidated financial statements for 2011 to “NASDAQ OMX Riga”. Audited financial results show that the turnover of the Group of «Grindeks» amounted to 69.6 million lats in 2011, which is by 4.5 million lats or 6.9% more than in 2010. In its turn, net profit related to the shareholders of the holding company amounted to 6.7 million lats in 2011, which, in comparison with 2010, has decreased by 0.4 million lats or 5.6%. In 2011, gross profit margin of the Group was 58.9%, whereas, net profit margin comprised 9.6%. Products of the Group, manufactured during the Year 2011, were exported to 50 countries worldwide for the total amount of 65.8 million lats.

Read more


Notification on convocation of joint stock company GRINDEKS Annual General Meeting of shareholders
27.04.2012
The Management Board of joint stock company «Grindeks» (registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057) calls up and announces that Annual General Meeting of Shareholders of joint stock company “«Grindeks»” will take place on June 19, 2012 at 11 a.m. at premises of joint stock company “«Grindeks»”, 53 Krustpils street, Riga, Latvia.

Read more


On «Grindeks» financial results for 2011
24.02.2012
Today, on 24 February, JSC «Grindeks» has submitted the non-audited consolidated financial statements for 2011 to “NASDAQ OMXRiga”. Non-audited financial results show that the turnover of the Group of «Grindeks» amounted to 69.6million lats in 2011, which is by 4.5 million lats or 6.9% more than in 2010. In its turn, net profit related to the shareholders of the holding company amounted to 6.7 million lats in 2011, which, in comparison with 2010, has decreasedby 0.4 million lats or 5.6%. In 2011, gross profit margin of the Group was 58.9%, whereas, net profit margin comprised 9.6%. Products of the Group, manufactured during the Year 2011, were exported to 50 countries worldwide for the total amountof 65.8 million lats.

Read more


«Grindeks»: EU-funded Competence Centres Program is important to the development of Latvia’s national economy
07.02.2012
JSC «Grindeks» informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence Centre”.

Read more